Top

International Journal of Diabetes in Developing Countries

Published in:

01-09-2015 | Original Article

Depressive symptoms and clustering of cardiovascular disease risk factors in diabetes patients

Authors: Reema A. Karasneh, Sayer I. Al-Azzam, Karem H. Alzoubi, Jaafar A. Abu Abeeleh, Yousef S. Khader

Published in: International Journal of Diabetes in Developing Countries | Special Issue 2/2015

Abstract

Depressive symptoms may be related to the development of coronary heart disease (CHD) in patients with diabetes mellitus. The objective of the present study was to investigate the relationship between cardiovascular disease risk factors and depressive symptoms in patients with type 2 diabetes. A total of 179 patients with type 2 diabetes completed a questionnaire and gave a blood sample. The questionnaire consisted of demographics, the medication adherence questionnaire, the summary of diabetes self-care activities questionnaire, and the Beck Depression Inventory II questionnaire. Blood samples were analyzed for glucose and lipid profile. Elevated depression Beck score had a significant relation with female gender, numbness or pain in peripheries, younger age group ≤50 years, and elevated triglycerides (TG). Diabetes complications also had a significant relation with depression and more specifically with performance impairment and depression-nonspecific items. A significant relation was found between uncontrolled diabetes and somatic disturbance. Under-adherence to medications was significantly related to depression-specific items. Obesity was significantly related to depression-nonspecific items. Several factors are correlated with depression symptoms in diabetes patients. Additionally, control of somatic disturbance and performance impairment of depression should be regarded as important components of appropriate diabetes care to ensure diabetes control and medication adherence.

Lam DW, LeRoith D. The worldwide diabetes epidemic. Curr Opin Endocrinol Diabetes Obes. 2012;19(2):93–6. doi:10.1097/MED.0b013e328350583a.CrossRefPubMed

Kesteloot H. On the relative importance of cardiovascular disease and cancer as causes of death: the effect of age and sex. Acta Cardiol. 2008;63(3):293–5.CrossRefPubMed

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.CrossRefPubMed

Bonow RO, Smaha LA, Smith Jr SC, Mensah GA, Lenfant C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation. 2002;106(13):1602–5.CrossRefPubMed

Preis SR, Pencina MJ, Hwang SJ, D'Agostino Sr RB, Savage PJ, Levy D, et al. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation. 2009;120(3):212–20. doi:10.1161/CIRCULATIONAHA.108.846519.PubMedCentralCrossRefPubMed

Fox CS. Cardiovascular disease risk factors, type 2 diabetes mellitus, and the Framingham Heart Study. Trends Cardiovasc Med. 2010;20(3):90–5. doi:10.1016/j.tcm.2010.08.001.PubMedCentralCrossRefPubMed

deGoma EM, Knowles JW, Angeli F, Budoff MJ, Rader DJ. The evolution and refinement of traditional risk factors for cardiovascular disease. Cardiol Rev. 2012;20(3):118–29. doi:10.1097/CRD.0b013e318239b924.PubMedCentralCrossRefPubMed

Joynt KE, Whellan DJ, O’Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry. 2003;54(3):248–61.CrossRefPubMed

Katon WJ, Lin EH, Russo J, Von Korff M, Ciechanowski P, Simon G, et al. Cardiac risk factors in patients with diabetes mellitus and major depression. J Gen Intern Med. 2004;19(12):1192–9. doi:10.1111/j.1525-1497.2004.30405.x.PubMedCentralCrossRefPubMed

10.

Lichtman JH, Bigger Jr JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768–75. doi:10.1161/CIRCULATIONAHA.108.190769.CrossRefPubMed

11.

Paile-Hyvarinen M, Raikkonen K, Forsen T, Kajantie E, Yliharsila H, Salonen MK, et al. Depression and its association with diabetes, cardiovascular disease, and birth weight. Ann Med. 2007;39(8):634–40. doi:10.1080/07853890701545722.CrossRefPubMed

12.

Labad J, Price JF, Strachan MW, Fowkes FG, Ding J, Deary IJ, et al. Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia. 2010;53(3):467–71. doi:10.1007/s00125-009-1628-9.PubMedCentralCrossRefPubMed

13.

Rubin RR, Gaussoin SA, Peyrot M, DiLillo V, Miller K, Wadden TA, et al. Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes. Diabetologia. 2010;53(8):1581–9. doi:10.1007/s00125-010-1765-1.PubMedCentralCrossRefPubMed

14.

Nichols GA, Moler EJ. Cardiovascular disease, heart failure, chronic kidney disease and depression independently increase the risk of incident diabetes. Diabetologia. 2011;54(3):523–6. doi:10.1007/s00125-010-1965-8.PubMedCentralCrossRefPubMed

15.

Huang CY, Chi SC, Sousa VD, Wang CP, Pan KC. Depression, coronary artery disease, type 2 diabetes, metabolic syndrome and quality of life in Taiwanese adults from a cardiovascular department of a major hospital in Southern Taiwan. J Clin Nurs. 2011;20(9-10):1293–302. doi:10.1111/j.1365-2702.2010.03451.x.CrossRefPubMed

16.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421.

17.

Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.CrossRefPubMed

18.

Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–50.CrossRefPubMed

19.

Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med. 1997;59(1):24–31.CrossRefPubMed

20.

Uslu RI, Kapci EG, Oncu B, Ugurlu M, Turkcapar H. Psychometric properties and cut-off scores of the Beck Depression Inventory-II in Turkish adolescents. J Clin Psychol Med Settings. 2008;15(3):225–33. doi:10.1007/s10880-008-9122-y.CrossRefPubMed

21.

Byrne BM. Factor analytic models: viewing the structure of an assessment instrument from three perspectives. J Pers Assess. 2005;85(1):17–32. doi:10.1207/s15327752jpa8501_02.CrossRefPubMed

22.

Morley S, Williams AC, Black S. A confirmatory factor analysis of the Beck Depression Inventory in chronic pain. Pain. 2002;99(1-2):289–98.CrossRefPubMed

23.

Wang YP, Lederman LP, Andrade LH, Gorenstein C. Symptomatic expression of depression among Jewish adolescents: effects of gender and age. Soc Psychiatry Psychiatr Epidemiol. 2008;43(1):79–86. doi:10.1007/s00127-007-0270-4.CrossRefPubMed

24.

Gorenstein C, Andrade L, Zanolo E, Artes R. Expression of depressive symptoms in a nonclinical Brazilian adolescent sample. Can J Psychiatry. 2005;50(3):129–36.PubMed

25.

Wang YP, Andrade LH, Gorenstein C. Validation of the Beck Depression Inventory for a Portuguese-speaking Chinese community in Brazil. Braz J Med Biol Res. 2005;38(3):399–408. doi:10.1590/S0100-879X2005000300011.CrossRefPubMed

26.

Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89(6):2595–600. doi:10.1210/jc.2004-0372.CrossRefPubMed

27.

Lee HJ, Chapa D, Kao CW, Jones D, Kapustin J, Smith J, et al. Depression, quality of life, and glycemic control in individuals with type 2 diabetes. J Am Acad Nurse Pract. 2009;21(4):214–24. doi:10.1111/j.1745-7599.2009.00396.x.CrossRefPubMed

28.

Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ. 2007;33(6):1014–29. doi:10.1177/0145721707308407. discussion 30-1.CrossRefPubMed

29.

Katon WJ, Russo JE, Heckbert SR, Lin EH, Ciechanowski P, Ludman E, et al. The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes. Int J Geriatr Psychiatry. 2010;25(5):466–75. doi:10.1002/gps.2363.CrossRefPubMed

30.

Gonzalez JS, Safren SA, Delahanty LM, Cagliero E, Wexler DJ, Meigs JB, et al. Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes. Diabet Med. 2008;25(9):1102–7. doi:10.1111/j.1464-5491.2008.02535.x.PubMedCentralCrossRefPubMed

31.

Shehatah A, Rabie MA, Al-Shahry A. Prevalence and correlates of depressive disorders in elderly with type 2 diabetes in primary health care settings. J Affect Disord. 2010;123(1-3):197–201. doi:10.1016/j.jad.2009.09.002.CrossRefPubMed

32.

de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63(4):619–30.CrossRefPubMed

Title: Depressive symptoms and clustering of cardiovascular disease risk factors in diabetes patients
Authors: Reema A. Karasneh
Sayer I. Al-Azzam
Karem H. Alzoubi
Jaafar A. Abu Abeeleh
Yousef S. Khader
Publication date: 01-09-2015
Publisher: Springer India
Published in: International Journal of Diabetes in Developing Countries / Issue Special Issue 2/2015
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-015-0382-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2015

Quality of life in people with type 2 diabetes living in rural and remote areas, Iran

Determinants of quality of life in elderly patients with type 2 diabetes treated in hospital and outpatient clinic: a comparative study

Validity and reliability of the Turkish version of the Diabetes Self-Care Scale

Imbalance in inpatient costs between urban and rural diabetes patients in Jinan, China

Illness perceptions and perceived barriers to self-care in patients with type 2 diabetes mellitus: an exploratory study from India

Health-related quality of life among children with type 1 diabetes in Saudi Arabia

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials